• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

The flu season is making a shortage of IV fluids worse – here’s what the FDA is doing about it

February 2, 2018 By Sarah Faulkner

IV fluidsThis year’s flu season has been exceptionally bad – it’s already claimed the lives of dozens of kids and it’s more widespread than any other year on record, according to the Centers for Disease Control and Prevention.

It’s also making a shortage of intravenous fluids and IV bags worse than it already is.

IV saline bags have long been in short supply, but the issue was exacerbated by Hurricane Maria’s impact on Puerto Rico and the medical device manufacturers that have facilities on the island. FDA commissioner Dr. Scott Gottlieb has been working with suppliers to get their manufacturing plants back on Puerto Rico’s electrical grid, but the devastation left behind by the hurricane has made it challenging for manufacturers to ramp up to full capacity.

Last month, the FDA chief reported that the agency’s efforts, combined with those of local lawmakers and companies like Baxter (NYSE:BAX), are proving useful. The shortage should improve the coming weeks and months, he said.

But the ill-timed flu season isn’t helping the situation.

“Although the saline shortage is improving, this year’s worse-than-normal flu season and workarounds deployed by healthcare providers in the wake of this shortage have increased demand for saline and other products,” Gottlieb noted today in prepared remarks.

Large volume saline bags, which are usually used to hydrate patients, and small volume IV bags, which are used to deliver medicine, are in short supply. Now that healthcare workers are filling empty IV containers to compound their own IV saline solutions, Gottlieb is worried that the empty containers could be next on the shortage list.

Some providers have told the FDA that there are spot shortages of certain antivirals used to combat the flu, as well as flu tests. There isn’t a nationwide shortage, Gottlieb said, but the FDA is reportedly keeping a close eye on the situation.

“Along with antivirals and device products we are also monitoring influenza vaccine supplies. While there have been some reported spot shortages, flu vaccines are still available,” he added. “I strongly encourage anyone who hasn’t had a flu shot to get one and anyone experiencing flu-like symptoms to promptly consult with their health care provider about appropriate treatment options.”

In an attempt to mitigate the IV fluid bag shortage, the FDA has extended the expiration dates of certain large volume saline bags. The agency reviewed safety data submitted by the company and determined that the product could be safely used for longer than originally determined.

Gottlieb also said the FDA is working with Baxter and B. Braun to bring products from foreign facilities into the U.S.

The flu season is expected to reach its peak soon, Gottlieb said, and the FDA chief is looking at this experience as a lesson learned.

“The hurricanes and flu season have underscored the importance of preparedness and connectivity across the agency, the industries we regulate, as well as distributors and health care providers to best serve patients that need access to these critical products,” he said.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Hospital Care, Pharmaceuticals, Regulatory/Compliance, Wall Street Beat Tagged With: B. Braun Medical, Baxter International, FDA

IN CASE YOU MISSED IT

  • Billie Jean King supports Medtronic Diabetes awareness initiative
  • Tandem stock rises after hours on Q3 beats, record sales
  • Insulet leadership talks patch pump competition, expanding type 2 diabetes market
  • Insulet increases guidance again on Q3 beats, 30% sales uptick
  • Senseonics posts Q3 sales beat, expects CE mark for Eversense 365 this year

Reader Interactions

Comments

  1. IV Hydration says

    September 4, 2018 at 1:18 pm

    Very helpful information shared. Keep it up.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS